JENTADUETO®: Linagliptin and metformin combined in a convenient, singe small pill.

JENTADUETO® is conveniently available in multiple metformin strengths for dosing flexibility:1

 

JENTADUETO® is conveniently available in multiple metformin strengths for dosing flexibility (D2/850)
JENTADUETO® is conveniently available in multiple metformin strengths for dosing flexibility (D2/1000)

JENTADUETO® has the appropriate dosing for patients with moderate renal impairment (CKD3a):1

 

JENTADUETO® has the appropriate dosing for patients with moderate renal impairment (CKD3a)

Thanks to this renal profile, linagliptin does not need to be adjusted based on renal function.1,2 The dose will always be 5 mg daily.1,2 That means when you need to treat your T2D patients with a combination pill, you can start simple with the single-pill combination JENTADUETO® (taken bi-daily).1,2 When renal function declines and metformin must be removed, you can stay simple with TRAJENTA®, which will keep your patients on the same DPP4i dose of 5 mg (taken once daily).1,2

*Including metabolites and unchanged drug; excretion after single dose administration of C14-labelled drug.